ACRS Q2 2017 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$407M

Q2 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$15M

Net Income

-$15M

EPS (Diluted)

$-0.56

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$177M

Total Liabilities

$9M

Stockholders' Equity

$168M

Cash & Equivalents

$33M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$15M	-$13M	-17.8%
Net Income	-$15M	-$13M	-15.3%